Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T12:45:46.924Z.
Calculation as of: 2026-10-06T12:45:46.924Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Market Cap
$1.52B
EV/EBIT Ratio
93.55x
TTM Avg
402.45x
3Y Avg
215.28x
5Y Avg
215.28x
Market Cap
$1.45B
EV/EBIT Ratio
10.01x
TTM Avg
25.95x
3Y Avg
23.59x
5Y Avg
24.10x
Market Cap
$1.43B
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.65B
EV/EBIT Ratio
N/A
TTM Avg
33.08x
3Y Avg
33.08x
5Y Avg
33.08x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | $1.51B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.52B | N/A | N/A | N/A | N/A |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 93.55x | 402.45x | 215.28x | 215.28x |
| AnaptysBio, Inc. (ANAB)vs › | $1.46B | 11.89x | 36.76x | 36.76x | 36.50x |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 10.01x | 25.95x | 23.59x | 24.10x |
| Certara, Inc. (CERT)vs › | $1.57B | 220.44x | 79.44x | 108.81x | 130.77x |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.43B | N/A | N/A | N/A | N/A |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.39B | N/A | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | N/A | 33.08x | 33.08x | 33.08x |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 10.79x | 32.14x | 262.80x | 252.98x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
